Literature DB >> 18340531

Tenoxicam modulates antioxidant redox system and lipid peroxidation in rat brain.

Mustafa Naziroğlu1, Abdulhadi Cihangir Uğuz, Alpaslan Gokçimen, Metin Bülbül, Dilek Ulusoy Karatopuk, Yasin Türker, Celal Cerçi.   

Abstract

We investigated effects of two doses of Tenoxicam, a type 2 cyclooxygenase inhibitor, administration on lipid peroxidation and antioxidant redox system in cortex of the brain in rats. Twenty-two male Wistar rats were randomly divided into three groups. First group was used as control. 10 and 20 mg/kg body weight Tenoxicam were intramuscularly administrated to rats constituting the second and third groups for 10 days, respectively. Both dose of Tenoxicam administration resulted in significant increase in the glutathione peroxidase activity, reduced glutathione and vitamins C and E of cortex of the brain. The lipid peroxidation levels in the cortex of the brain were significantly decreased by the administration. Vitamin A and beta-carotene concentration was not affected by the administration. There was no statistical difference in all values between 10 and 20 mg Tenoxicam administrated groups. In conclusion, treatment of brain with 10 and 20 mg Tenoxicam has protective effects on the oxidative stress by inhibiting free radical and supporting antioxidant redox system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340531     DOI: 10.1007/s11064-008-9643-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  Effect of therapeutic plasma concentrations of non-steroidal anti-inflammatory drugs on the production of reactive oxygen species by activated rat neutrophils.

Authors:  I M M Paino; V F Ximenes; L M da Fonseca; M P P Kanegae; N M Khalil; I L Brunetti
Journal:  Braz J Med Biol Res       Date:  2005-04-13       Impact factor: 2.590

2.  Effect of tenoxicam on inflammation and immune cellular function.

Authors:  M A Scheinberg; J Santoro; M L Sanchez
Journal:  Braz J Med Biol Res       Date:  1990       Impact factor: 2.590

Review 3.  Selenium and the brain: a review.

Authors:  P D Whanger
Journal:  Nutr Neurosci       Date:  2001       Impact factor: 4.994

4.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

5.  Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

Authors:  Ibrahim Eren; Mustafa Naziroğlu; Arif Demirdaş; Omer Celik; A Cihangir Uğuz; Ayşe Altunbaşak; Ismail Ozmen; Efkan Uz
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

6.  Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury.

Authors:  J M Schwab; K Brechtel; T D Nguyen; H J Schluesener
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

7.  Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury.

Authors:  Weiya Ma; Wei Du; James C Eisenach
Journal:  Brain Res       Date:  2002-05-24       Impact factor: 3.252

Review 8.  Non-antioxidant activities of vitamin E.

Authors:  Jean-Marc Zingg; Angelo Azzi
Journal:  Curr Med Chem       Date:  2004-05       Impact factor: 4.530

9.  In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families.

Authors:  Pierre Van Antwerpen; Jean Nève
Journal:  Eur J Pharmacol       Date:  2004-08-02       Impact factor: 4.432

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  6 in total

1.  Antioxidant activity of topiramate: an antiepileptic agent.

Authors:  N Cárdenas-Rodríguez; E Coballase-Urrutia; B Huerta-Gertrudis; M E García-Cruz; J Pedraza-Chaverri; R Coria-Jiménez; C Bandala; M Ruíz-García
Journal:  Neurol Sci       Date:  2012-06-04       Impact factor: 3.307

2.  Evaluation of tenoxicam on prevention of arachnoiditis in rat laminectomy model.

Authors:  Berker Cemil; Gokhan Kurt; Cansel Aydın; Nalan Akyurek; Bulent Erdogan; Necdet Ceviker
Journal:  Eur Spine J       Date:  2011-02-15       Impact factor: 3.134

3.  Selenium and topiramate modulates brain microsomal oxidative stress values, Ca2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats.

Authors:  Mustafa Naziroğlu; Süleyman Kutluhan; Mustafa Yilmaz
Journal:  J Membr Biol       Date:  2008-10-24       Impact factor: 1.843

Review 4.  Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models.

Authors:  Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Liliana Rivera-Espinosa; Arantxa Romero-Toledo; Aristides Sampieri; Daniel Ortega-Cuellar; Hortencia Montesinos-Correa; Esaú Floriano-Sánchez; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2013-12-17       Impact factor: 6.543

Review 5.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

Review 6.  Effects of Ibuprofen Compared to Other Premedication Drugs on the Risk and Intensity of Postendodontic Pain: A Systematic Review.

Authors:  Juliana L De Geus; Letícia M Wambier; Thaynara F Boing; Alessandro D Loguercio; Alessandra Reis
Journal:  Eur Endod J       Date:  2018-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.